aluates Reports

$ 0.0

Automative

Global Cyclooxygenase 2 Inhibitor Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-29C1882

Global Cyclooxygenase 2 Inhibitor Market Insights and Forecast to 2028

BUY CHAPTERS

Global Cyclooxygenase 2 Inhibitor Market Research Report 2025

Code: QYRE-Auto-29C1882

Report

September 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Bayer

Novartis

Merck

Sabinsa

Cadila Pharmaceuticals

Mylan NV

Teva Pharmaceutical

Alembic Pharmaceutical

Aurobindo Pharma

Cipla Ltd

Torrent Pharmaceuticals

Cyclooxygenase 2 Inhibitor Market

The global market for Cyclooxygenase 2 Inhibitor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

COX inhibitors are mostly antipyretic and analgesic anti-inflammatory drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 has extremely low activity in normal tissue cells, and can only be produced in large quantities when induced. It mediates pain, inflammation, and fever by promoting PG synthesis. In general, multiple adverse effects of non-steroidal anti-inflammatory drugs are believed to be related to the inhibition of COX-1. As a result, COX-2 selective inhibitors have emerged.

North American market for Cyclooxygenase 2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cyclooxygenase 2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Cyclooxygenase 2 Inhibitor in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cyclooxygenase 2 Inhibitor include Pfizer, Bayer, Novartis, Merck, Sabinsa, Cadila Pharmaceuticals, Mylan, Teva Pharmaceutical, Alembic Pharmaceutical, Aurobindo Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cyclooxygenase 2 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclooxygenase 2 Inhibitor.

The Cyclooxygenase 2 Inhibitor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclooxygenase 2 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cyclooxygenase 2 Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cyclooxygenase 2 Inhibitor Market Report

Report Metric	Details
Report Name	Cyclooxygenase 2 Inhibitor Market
Segment by Type	Selective Cox 2 Inhibitor Non-Selective Cox 2 Inhibitor
Segment by Application	Hospital Specialty Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bayer, Novartis, Merck, Sabinsa, Cadila Pharmaceuticals, Mylan, Teva Pharmaceutical, Alembic Pharmaceutical, Aurobindo Pharma, Cipla, Torrent Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyclooxygenase 2 Inhibitor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cyclooxygenase 2 Inhibitor Market report?

Ans: The main players in the Cyclooxygenase 2 Inhibitor Market are Pfizer, Bayer, Novartis, Merck, Sabinsa, Cadila Pharmaceuticals, Mylan, Teva Pharmaceutical, Alembic Pharmaceutical, Aurobindo Pharma, Cipla, Torrent Pharmaceuticals

What are the Application segmentation covered in the Cyclooxygenase 2 Inhibitor Market report?

Ans: The Applications covered in the Cyclooxygenase 2 Inhibitor Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Cyclooxygenase 2 Inhibitor Market report?

Ans: The Types covered in the Cyclooxygenase 2 Inhibitor Market report are Selective Cox 2 Inhibitor, Non-Selective Cox 2 Inhibitor

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Selective Cox 2 Inhibitor

1.2.3 Non-Selective Cox 2 Inhibitor

1.3 Market by Application

1.3.1 Global Cyclooxygenase 2 Inhibitor Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Specialty Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cyclooxygenase 2 Inhibitor Market Perspective (2020-2031)

2.2 Global Cyclooxygenase 2 Inhibitor Growth Trends by Region

2.2.1 Global Cyclooxygenase 2 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cyclooxygenase 2 Inhibitor Historic Market Size by Region (2020-2025)

2.2.3 Cyclooxygenase 2 Inhibitor Forecasted Market Size by Region (2026-2031)

2.3 Cyclooxygenase 2 Inhibitor Market Dynamics

2.3.1 Cyclooxygenase 2 Inhibitor Industry Trends

2.3.2 Cyclooxygenase 2 Inhibitor Market Drivers

2.3.3 Cyclooxygenase 2 Inhibitor Market Challenges

2.3.4 Cyclooxygenase 2 Inhibitor Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue

3.1.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue (2020-2025)

3.1.2 Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Players (2020-2025)

3.2 Global Cyclooxygenase 2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cyclooxygenase 2 Inhibitor Revenue

3.4 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio

3.4.1 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cyclooxygenase 2 Inhibitor Revenue in 2024

3.5 Global Key Players of Cyclooxygenase 2 Inhibitor Head office and Area Served

3.6 Global Key Players of Cyclooxygenase 2 Inhibitor, Product and Application

3.7 Global Key Players of Cyclooxygenase 2 Inhibitor, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cyclooxygenase 2 Inhibitor Breakdown Data by Type

4.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Type (2020-2025)

4.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2026-2031)

5 Cyclooxygenase 2 Inhibitor Breakdown Data by Application

5.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Application (2020-2025)

5.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cyclooxygenase 2 Inhibitor Market Size (2020-2031)

6.2 North America Cyclooxygenase 2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025)

6.4 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cyclooxygenase 2 Inhibitor Market Size (2020-2031)

7.2 Europe Cyclooxygenase 2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025)

7.4 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size (2020-2031)

8.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025)

8.4 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cyclooxygenase 2 Inhibitor Market Size (2020-2031)

9.2 Latin America Cyclooxygenase 2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025)

9.4 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size (2020-2031)

10.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025)

10.4 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Introduction

11.1.4 Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Bayer Business Overview

11.2.3 Bayer Cyclooxygenase 2 Inhibitor Introduction

11.2.4 Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.2.5 Bayer Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Cyclooxygenase 2 Inhibitor Introduction

11.3.4 Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Cyclooxygenase 2 Inhibitor Introduction

11.4.4 Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Sabinsa

11.5.1 Sabinsa Company Details

11.5.2 Sabinsa Business Overview

11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Introduction

11.5.4 Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.5.5 Sabinsa Recent Development

11.6 Cadila Pharmaceuticals

11.6.1 Cadila Pharmaceuticals Company Details

11.6.2 Cadila Pharmaceuticals Business Overview

11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction

11.6.4 Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.6.5 Cadila Pharmaceuticals Recent Development

11.7 Mylan

11.7.1 Mylan Company Details

11.7.2 Mylan Business Overview

11.7.3 Mylan Cyclooxygenase 2 Inhibitor Introduction

11.7.4 Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.7.5 Mylan Recent Development

11.8 Teva Pharmaceutical

11.8.1 Teva Pharmaceutical Company Details

11.8.2 Teva Pharmaceutical Business Overview

11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction

11.8.4 Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.8.5 Teva Pharmaceutical Recent Development

11.9 Alembic Pharmaceutical

11.9.1 Alembic Pharmaceutical Company Details

11.9.2 Alembic Pharmaceutical Business Overview

11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction

11.9.4 Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.9.5 Alembic Pharmaceutical Recent Development

11.10 Aurobindo Pharma

11.10.1 Aurobindo Pharma Company Details

11.10.2 Aurobindo Pharma Business Overview

11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Introduction

11.10.4 Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.10.5 Aurobindo Pharma Recent Development

11.11 Cipla

11.11.1 Cipla Company Details

11.11.2 Cipla Business Overview

11.11.3 Cipla Cyclooxygenase 2 Inhibitor Introduction

11.11.4 Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.11.5 Cipla Recent Development

11.12 Torrent Pharmaceuticals

11.12.1 Torrent Pharmaceuticals Company Details

11.12.2 Torrent Pharmaceuticals Business Overview

11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction

11.12.4 Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025)

11.12.5 Torrent Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Bayer

Novartis

Merck

Sabinsa

Cadila Pharmaceuticals

Mylan NV

Teva Pharmaceutical

Alembic Pharmaceutical

Aurobindo Pharma

Cipla Ltd

Torrent Pharmaceuticals

List of Tables

Table 1. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Selective Cox 2 Inhibitor

Table 3. Key Players of Non-Selective Cox 2 Inhibitor

Table 4. Global Cyclooxygenase 2 Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Cyclooxygenase 2 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Cyclooxygenase 2 Inhibitor Market Share by Region (2020-2025)

Table 8. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Cyclooxygenase 2 Inhibitor Market Share by Region (2026-2031)

Table 10. Cyclooxygenase 2 Inhibitor Market Trends

Table 11. Cyclooxygenase 2 Inhibitor Market Drivers

Table 12. Cyclooxygenase 2 Inhibitor Market Challenges

Table 13. Cyclooxygenase 2 Inhibitor Market Restraints

Table 14. Global Cyclooxygenase 2 Inhibitor Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Cyclooxygenase 2 Inhibitor Market Share by Players (2020-2025)

Table 16. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2024)

Table 17. Ranking of Global Top Cyclooxygenase 2 Inhibitor Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Cyclooxygenase 2 Inhibitor Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Cyclooxygenase 2 Inhibitor, Headquarters and Area Served

Table 20. Global Key Players of Cyclooxygenase 2 Inhibitor, Product and Application

Table 21. Global Key Players of Cyclooxygenase 2 Inhibitor, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2020-2025)

Table 25. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2026-2031)

Table 27. Global Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2020-2025)

Table 29. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2026-2031)

Table 31. North America Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Cyclooxygenase 2 Inhibitor Product

Table 49. Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Bayer Company Details

Table 52. Bayer Business Overview

Table 53. Bayer Cyclooxygenase 2 Inhibitor Product

Table 54. Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 55. Bayer Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Cyclooxygenase 2 Inhibitor Product

Table 59. Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Merck Company Details

Table 62. Merck Business Overview

Table 63. Merck Cyclooxygenase 2 Inhibitor Product

Table 64. Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 65. Merck Recent Development

Table 66. Sabinsa Company Details

Table 67. Sabinsa Business Overview

Table 68. Sabinsa Cyclooxygenase 2 Inhibitor Product

Table 69. Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 70. Sabinsa Recent Development

Table 71. Cadila Pharmaceuticals Company Details

Table 72. Cadila Pharmaceuticals Business Overview

Table 73. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product

Table 74. Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 75. Cadila Pharmaceuticals Recent Development

Table 76. Mylan Company Details

Table 77. Mylan Business Overview

Table 78. Mylan Cyclooxygenase 2 Inhibitor Product

Table 79. Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 80. Mylan Recent Development

Table 81. Teva Pharmaceutical Company Details

Table 82. Teva Pharmaceutical Business Overview

Table 83. Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Product

Table 84. Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 85. Teva Pharmaceutical Recent Development

Table 86. Alembic Pharmaceutical Company Details

Table 87. Alembic Pharmaceutical Business Overview

Table 88. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product

Table 89. Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 90. Alembic Pharmaceutical Recent Development

Table 91. Aurobindo Pharma Company Details

Table 92. Aurobindo Pharma Business Overview

Table 93. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product

Table 94. Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 95. Aurobindo Pharma Recent Development

Table 96. Cipla Company Details

Table 97. Cipla Business Overview

Table 98. Cipla Cyclooxygenase 2 Inhibitor Product

Table 99. Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 100. Cipla Recent Development

Table 101. Torrent Pharmaceuticals Company Details

Table 102. Torrent Pharmaceuticals Business Overview

Table 103. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product

Table 104. Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2020-2025) & (US$ Million)

Table 105. Torrent Pharmaceuticals Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Cyclooxygenase 2 Inhibitor Picture

Figure 2. Global Cyclooxygenase 2 Inhibitor Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cyclooxygenase 2 Inhibitor Market Share by Type: 2024 VS 2031

Figure 4. Selective Cox 2 Inhibitor Features

Figure 5. Non-Selective Cox 2 Inhibitor Features

Figure 6. Global Cyclooxygenase 2 Inhibitor Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Specialty Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Cyclooxygenase 2 Inhibitor Report Years Considered

Figure 12. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Cyclooxygenase 2 Inhibitor Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Cyclooxygenase 2 Inhibitor Market Share by Region: 2024 VS 2031

Figure 15. Global Cyclooxygenase 2 Inhibitor Market Share by Players in 2024

Figure 16. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2024

Figure 18. North America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Cyclooxygenase 2 Inhibitor Market Share by Country (2020-2031)

Figure 20. United States Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Cyclooxygenase 2 Inhibitor Market Share by Country (2020-2031)

Figure 24. Germany Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Region (2020-2031)

Figure 32. China Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Cyclooxygenase 2 Inhibitor Market Share by Country (2020-2031)

Figure 40. Mexico Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Country (2020-2031)

Figure 44. Turkey Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 48. Bayer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 51. Sabinsa Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 52. Cadila Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 53. Mylan Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 54. Teva Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 55. Alembic Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 56. Aurobindo Pharma Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 57. Cipla Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 58. Torrent Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cox 2 Inhibitors Market

Global Specific COX 2 Inhibitors Market Research Report 2024

Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030

Global Selective Cox 2 Inhibitors Market Research Report 2024

Global Indomethacin Tablets Market Research Report 2024

Global Piroxicam Market Research Report 2024

Global Celecoxib Market Insights Forecast to 2030

Global Tenoxicam Market Research Report 2024

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Global Tiaprofenic Acid Market Research Report 2024

Global Celecoxib API Market Research Report 2025

Global Loxoprofen Sodium Market Research Report 2024

Global Meloxicam Market Research Report 2024

Global Pets NSAIDs Market Research Report 2025

Global Nimesulide Market Research Report 2024

Global Indometacin Indomethacin Market Research Report 2024

Global Anti inflammatory Agents Market Research Report 2024

Global Celecoxib Capsule Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions